Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDTY.L Regulatory News (DTY)

  • There is currently no data for DTY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Response to statement made by Phoenix

13 Apr 2021 07:00

RNS Number : 2178V
Dignity PLC
13 April 2021
 

Dignity plc (the "Company")

 

Response to statement made by Phoenix UK Fund Limited ("Phoenix") on 12 April 2021 

 

The independent directors of the Company (the "Independent Directors") note the most recent statement by Phoenix published on its website on 12 April 2021. They note, in particular, the various comments made by Phoenix regarding potential strategies that may be adopted for the future direction of the group's business.

 

It should come as no surprise that many of the ideas disclosed in Phoenix's most recent letter are amongst those currently being assessed in detail by the Board. In the Company's letter to shareholders dated 29 March 2021, the Independent Directors commented on the fact that the vision and views on strategy of Phoenix and those of the Board were already closely aligned, such that the requisitioned shareholder meeting was wholly unnecessary. The Board is well-advanced in its detailed planning towards the announcement of a fully thought-through strategy plan, including the possibility of a distribution of the Crematoria business to existing shareholders on a pro rata basis. It was always intended that the Board would announce its vision for the Company at the time of the Company's AGM in June 2021 and this has been indicated to the market for some time.

 

The Independent Directors find the statements made by Phoenix relating to possible strategies (and public reference to unverified valuations for the Crematoria division, in particular) to be deeply irresponsible. There are significant nuances to any strategic plan of this nature before it can be made public. The interests of all stakeholders need to be carefully addressed including, in this instance, the interests of bondholders and employees, as well as shareholders. There also needs to be a full and complete understanding of all potential regulatory aspects, so that the Board can be sure of its capacity to deliver any publicly announced strategy before it is announced. The Board has already indicated that it is well-aware of the potential value of different elements of the business on a stand-alone basis and of course a core objective is to unlock value for the benefit of all shareholders. However, it is inappropriate to hypothesize on strategies until there is sufficient confidence in a methodology to deliver the same. That Phoenix has chosen to "go public" on these matters prematurely serves only as a further illustration of the lack of suitability of Gary Channon to be appointed as someone responsible for the executive function of the Company.

 

Not for the first time since the Board convened the General Meeting to consider the resolutions proposed, Phoenix has made ill-advised public statements which have been self-serving and have had little regard for the wider interests of shareholders and other stakeholders. The Board has been informed by proxy voting agents, ISS, Glass Lewis and PIRC, that they are advising their members to support the Board and vote against both resolutions at the forthcoming General Meeting. In light of Phoenix's most recent statements, the Independent Directors are more convinced than ever that it is in the best interests of shareholders to allow the current management team to finish its work without handing executive control to Phoenix.

 

The Independent Directors have no hesitation in repeating their recommendation that shareholders should vote AGAINST the resolutions.

 

The Independent Directors of Dignity plc

Gillian Kent, Dean Moore and Paul Humphreys

 

 

Chris Lane

Tilly Abraham

Buchanan +44 (0)20 7466 5000

www.buchanan.uk.com Dignity@buchanan.uk.com

 

13 April 2021

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RSPGPUCUCUPGPGP
Date   Source Headline
17th Oct 202211:05 amRNSNotification of Major Holdings
12th Oct 20224:41 pmRNSSecond Price Monitoring Extn
12th Oct 20224:35 pmRNSPrice Monitoring Extension
30th Sep 20227:00 amRNSInterim Results
29th Sep 202211:31 amRNSResults of Consent Solicitation with Bondholders
15th Sep 20228:37 amRNSChange in Director’s Particulars
15th Sep 20227:00 amRNSUpdate to release date of 2022 Half-Year Results
7th Sep 20223:55 pmRNSConsent solicitation with Noteholders
31st Aug 20228:55 amRNSVoting Rights and Capital
29th Jul 202210:01 amRNSVoting Rights and Capital
29th Jul 20227:46 amRNSFCA Regulation
20th Jul 20229:00 amRNSDignity Announces Aim to be Net Zero By 2038
30th Jun 20224:50 pmRNSVoting Rights and Capital
17th Jun 20227:25 amRNS“intending to authorise” status from the FCA
14th Jun 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
9th Jun 20223:12 pmRNSBoard Update
9th Jun 202212:54 pmRNSResults of AGM
6th Jun 20227:00 amRNSNotification of Major Holdings
31st May 20227:00 amRNSVoting Rights and Capital
27th May 20222:52 pmRNSChange in Director’s Particulars
16th May 20227:00 amRNSAppointment of Chief Executive Officer
11th May 20227:00 amRNSFirst Quarter Trading Update
3rd May 202210:41 amRNSNotification of Major Holdings
29th Apr 20228:04 amRNS2021 Annual Report & Notice of 2022 AGM
29th Apr 20227:00 amRNSVoting Rights and Capital
14th Apr 202210:24 amRNSBLOCK LISTING SIX MONTHLY RETURN
4th Apr 202210:59 amRNSDirectorate Change
31st Mar 20227:00 amRNSTotal Voting Rights
30th Mar 202212:34 pmRNSNotification of Major Holdings
23rd Mar 20227:00 amRNSPreliminary Results
11th Mar 202211:49 amRNSResults of Bondholders Consent Solicitation
2nd Mar 20224:40 pmRNSSecond Price Monitoring Extn
2nd Mar 20224:35 pmRNSPrice Monitoring Extension
28th Feb 20227:00 amRNSVoting Rights and Capital
17th Feb 202210:30 amRNSTrading Update & Consent solicitation period
14th Feb 20227:00 amRNSNotification of Preliminary Results
12th Jan 202212:57 pmRNSBoard Appointment
7th Jan 20223:30 pmRNSBoard Appointments
31st Dec 20217:00 amRNSVoting Rights and Capital
17th Dec 20218:49 amRNSDirector Dealing Notification
14th Dec 202110:16 amRNSBLOCK LISTING SIX MONTHLY RETURN
30th Nov 20217:00 amRNSVoting Rights and Capital
8th Nov 20217:00 amRNSQ3 Trading Update
21st Oct 20217:00 amRNSAppointment of Joint Broker
14th Oct 20217:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
30th Sep 20217:00 amRNSVoting Rights and Capital
21st Sep 20217:00 amRNSInterim Results
1st Sep 20217:00 amRNSBoard Appointment
26th Jul 20217:00 amRNSBoard Appointment
12th Jul 20217:00 amRNSUpdate to release date of 2021 Half-Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.